Journey Medical Corp (DERM)

NASDAQ
Currency in USD
5.740
+0.170(+3.05%)
Closed
After Hours
5.7400.000(0.00%)
DERM Scorecard
Full Analysis
Significant return over the last week
Earnings results expected in 3 days
Fair Value
Day's Range
5.4775.750
52 wk Range
2.8506.890
Key Statistics
Edit
Prev. Close
5.57
Open
5.55
Day's Range
5.477-5.75
52 wk Range
2.85-6.89
Volume
50.62K
Average Volume (3m)
55.73K
1-Year Change
73.94%
Book Value / Share
0.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DERM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
10.000
Upside
+74.22%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year
Show more

Journey Medical Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

Employees
41

Compare DERM to Peers and Sector

Metrics to compare
DERM
Peers
Sector
Relationship
P/E Ratio
−6.5x−1.6x−0.5x
PEG Ratio
0.190.050.00
Price/Book
11.0x1.1x2.6x
Price / LTM Sales
2.1x3.0x3.0x
Upside (Analyst Target)
74.2%253.4%55.2%
Fair Value Upside
Unlock17.5%9.7%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.000
(+74.22% Upside)

Earnings

Latest Release
Nov 12, 2024
EPS / Forecast
-0.12 / -0.17
Revenue / Forecast
14.63M / 14.40M
EPS Revisions
Last 90 days

FAQ

What Is the Journey Medical (DERM) Stock Price Today?

The Journey Medical stock price today is 5.74.

What Stock Exchange Does Journey Medical Trade On?

Journey Medical is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Journey Medical?

The stock symbol for Journey Medical is "DERM."

What Is the Journey Medical Market Cap?

As of today, Journey Medical market cap is 119.91M.

What is Journey Medical Earnings Per Share?

The Journey Medical EPS is -0.927.

What Is the Next Journey Medical Earnings Date?

Journey Medical will release its next earnings report on 25 Mar 2025.

From a Technical Analysis Perspective, Is DERM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.